Discover 2,010 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,010
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Location: Hartford CT, New Haven CT, Hackensack NJ, Albany NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 7+
Code: NCT05705531
Recruiting
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
for
Peripheral T Cell Lymphoma
Location: New Brunswick NJ, Ottawa, Pembroke Pines FL, Toronto,
Sponsor: Acrotech Biopharma Inc.
Sex: All
Age: 18+
Code: NCT06072131
Phase3, Recruiting
Multifocal HD-tDCS and Motor Function
for
Healthy
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 65 - 70+
Code: NCT06561165
Recruiting
Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF)
for
Ileal Pouch
Location: New York NY, Hershey PA, Chapel Hill NC,
Sponsor: Exegi Pharma, LLC
Sex: All
Age: 18+
Code: NCT05938465
Phase1, Phase2, Recruiting
The PREDICT Registry:
for
DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ
Location: Boston MA, Mineola NY, Lake Success NY, New York NY,
Sponsor: PreludeDx
Sex: Female
Age: 30 - 70+
Code: NCT03448926
Recruiting
Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance
for
Obesity
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 15 - 70+
Code: NCT02043457
Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Nuvalent Inc.
Sex: All
Age: 12+
Code: NCT05384626
Phase1, Phase2, Recruiting
PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis
for
Graft Versus Host Disease
Location: Detroit MI
Sponsor: Henry Ford Health System
Sex: All
Age: 18 - 70
Code: NCT04886726
Phase1, Recruiting
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
for
Focal Segmental Glomerulosclerosis
Location: New York NY, Philadelphia PA, Wilmington DE,
Sponsor: Kaneka Medical America LLC
Sex: All
Age: 0 - 21
Code: NCT02235857
Recruiting
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
for
Biliary Tract Cancer
Location: Halifax, White Plains NY, Montreal, Towson MD,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06467357
Phase3, Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant
Location: Boston MA, New Haven CT, New York NY, Morristown NJ,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase3, Recruiting
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Boston MA, New York NY, Philadelphia PA, Columbus OH,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT04590326
Phase1, Phase2, Recruiting
Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
for
Head and Neck Cancer, Body Image Disturbance, Body Image,
Location: Hershey PA, Charleston SC, Detroit MI, St Louis MO,
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT05442957
Recruiting
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma